LOS ANGELES, March 27, 2017 -- Investor’s Business Daily (IBD), a leading financial news and research organization, today announced the results of its second annual Best Mutual Fund Awards. Funds named to the prestigious list were selected because they have beaten the broad market over the past one, three, five and 10 years -- an incredibly rare and difficult achievement.
“IBD is pleased to release its second annual Best Mutual Fund Awards list, using data culled and analyzed from a decade worth of returns. This distinguished list gives investors visibility into which mutual funds have the proven ability to adjust to market conditions and consistently exceed benchmarks so that investors can make the best decisions for their portfolios,” said Doug Rogers, IBD’s Funds & Personal Finance Editor. “These funds have shown their ability to outperform the market over both the long and short term, including through a highly volatile 2016.”
For the 2017 list, 2,813 mutual funds met the criteria of having at least $100 million in assets and 10 years of operation, but only 410 funds beat their performance benchmark across all four periods evaluated. Breaking it down further, of the 1,104 U.S. diversified stock mutual funds in business for the entire decade tracked by Morningstar Inc., only 44 prevailed at the one, three, five and 10 year marks.
Award winners were named across 12 categories: U.S. Diversified Equity Funds, Growth Funds, Blend Funds, Value Funds, Large-cap Funds, Mid-cap Funds, Small-cap Funds, Sector Funds, International Stock Funds, Taxable Bond Funds, Muni Funds, and International Bond Funds.
The complete list of winners can be found here: http://www.investors.com/mutualfundawards. Parnassus Endeavor Investor made the list for the second straight year, earning honors in both the U.S. Diversified Equity and the Growth categories as it soundly beat the S&P 500 benchmark each year evaluated. Victory Sycamore Established Value R topped the Value Fund list in impressive fashion, rounding out the categories arguably most popular among investors.
To find out more about this year’s winners, read analysis of the respective categories, and learn about how to invest in mutual funds, please visit http://www.investors.com/mutualfundawards.
About IBD
Investor's Business Daily is a leading financial news and research organization recognized for proprietary stock screens, comparative performance ratings and a record of identifying stock leaders as they emerge. The company takes a data-first approach to investing, educating investors about how to invest successfully using tested methods and sound research. IBD has honed its approach over the last 50 years to help investors make smarter decisions. Its stock lists have outperformed the S&P, and its recent presidential poll, the most accurate over the past four election cycles, was one of only two national polls to accurately predict the outcome of the 2016 Presidential Election. IBD offers a number of interactive stock research tools and information for investors of every level. To learn more about all that IBD has available, please visit www.investors.com.
For Editorial Contact: Marisa Lam GMK Communications for IBD [email protected] 650.544.3350


Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits 



